Adverse events following immunisation: desperately seeking surveillance

Lancet Infectious Diseases

Volumn 6, Issue 11, 2006, Pages 680-681

  Buttery, Jim ^a,b   La Vincente, Sophie ^a,c   Andrews, Ross ^a   Kempe, Ann ^a   Royle, Jenny ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; ROTAVIRUS VACCINE;

AUTISM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; IMMUNIZATION; INTUSSUSCEPTION; LETTER; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

AUSTRALIA; CANADA; CHILD; CHILD, PRESCHOOL; GERMANY; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; POPULATION SURVEILLANCE; PUBLIC HEALTH ADMINISTRATION; UNITED STATES;

EID: 33750194735     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70605-3     Document Type: Letter

References (14)

1. Zinka B., Rauch E., Buettner A., Rueff F., and Penning R. Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine 24 (2006) 5779-5780
2. von Kries R., Toschke A., Strassburger K., et al. Sudden and unexpected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, Haemophilius influenzae type b): is there a signal?. Eur J Pediatr 164 (2005) 61-69
3. Schmitt H., Siegrist C., Salmaso S., Law B., Booy R., Zinka B., et al. Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine 24 (2006) 5781-5782
4. von Kries R. Comment on B Zinka et al, Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine 24 (2006) 5783-5784
5. Zinka B., and Penning R. Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine 24 (2006) 5785-5786
6. Wilson C., and Marcuse E. Vaccine safety-vaccine benefits: science and the public's perception. Nat Rev Immunol 1 (2001) 160-165
7. Wright J., and Polack C. Understanding variation in measles-mumps-rubella immunization coverage-a population-based study. Eur J Public Health 16 (2006) 137-142
8. Wakefield A., Murch S., Anthony A., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351 (1998) 637-641
9. WHO. Immunzation Safety Surveillance (1999), World Health Organization Regional Office for the Western Pacific (WPRO), Manila
10. Chen R., and Hibbs B. Vaccine safety: current and future challenges. Pediatr Ann 27 (1998) 445-455
11. Scheifele D., and Halperin S. Immunization monitoring program, Active: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis 14 (2003) 213-219
12. Davis R., Kolczak M., Lewis E., et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 16 (2005) 336-341
13. Ali M., Canh G., Clemens J., et al. The use of a computerized database to monitor vaccine safety in Viet Nam. Bull World Health Organ 83 (2005) 604-610
14. Farrington P., Pugh S., Colville A., et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345 (1995) 567-569